Filing Details

Accession Number:
0000899243-23-005502
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-17 17:29:45
Reporting Period:
2023-02-15
Accepted Time:
2023-02-17 17:29:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1253689 Glycomimetics Inc GLYC () N4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1053906 S.a. Group Artal Valley Park, 44,
Rue De La Vallee
Luxembourg N4 L-2661
No No Yes No
1218180 S.c.a. International Artal Valley Park, 44,
Rue De La Vallee
Luxembourg N4 L-2661
No No Yes No
1283968 S.a. Westend Valley Park, 44,
Rue De La Vallee
Luxembourg N4 L-2661
No No Yes No
1340096 Invus Public Equities Advisors, Llc 750 Lexington Avenue 30Th Floor
New York NY 10022
No No Yes No
1340097 Invus Public Equities, L.p. 750 Lexington Avenue 30Th Floor
New York NY 10022
No No Yes No
1460840 Westend Administratiekantoor Stichting Claude Debussylaan, 46
Amsterdam P7 1082 MD
No No Yes No
1522131 S.a. Management International Artal Valley Park, 44,
Rue De La Vallee
Luxembourg N4 L-2661
No No Yes No
1841311 Amaury Wittouck Valley Park, 44,
Rue De La Vallee
Luxembourg N4 L-2661
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-15 1,000,000 $2.16 7,573,798 No 4 P Direct
Common Stock Acquisiton 2023-02-16 315,266 $1.68 7,889,064 No 4 P Direct
Common Stock Acquisiton 2023-02-17 200,000 $1.71 8,089,064 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The Common Stock is held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group, S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting").
  2. (Continued from Footnote 1) Mr. Amaury Wittouck is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.75 to $2.50 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.80 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.77 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.